Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Clinical Endpoints in Laser Treatment of Pigmented Lesions
Description
The speaker addresses an educational gap in laser dermatology, emphasizing that beginners need a better understanding of histology, skin imaging, and how lasers interact with pigmented lesions. The talk reviews the variety of pigmentary disorders—epidermal, dermal, and mixed—and notes that treatment is especially challenging in dark-skinned patients because of the higher risk of post-inflammatory hyperpigmentation and textural change. He explains the principle of selective photothermolysis and the key laser parameters: wavelength, pulse duration, and fluence, arguing that clinical endpoints are essential for choosing the right fluence in practice. Different lesions require different endpoints: superficial epidermal lesions may show subtle or immediate whitening, while dermal lesions require dermal whitening rather than aggressive whitening or pinpoint bleeding. Using examples such as solar lentigines, melasma, nevus of Ota, and complex mixed pigmentation, he shows that overly aggressive settings do not improve outcomes and instead increase complications like hyperpigmentation or hypopigmentation. He also highlights the role of histology and noninvasive imaging tools such as confocal microscopy and OCT to identify pigment depth, predict response, and reduce the need for biopsy. The lecture concludes with practical advice: match the endpoint to the pathology and lesion depth, stop when warning signs appear, and avoid simply increasing fluence or treatment frequency. Looking ahead, he envisions combining lasers with OCT, confocal imaging, and AI to automate parameter selection, but stresses that clinicians must first master endpoint recognition.
View moreConclusions
- Pigmentary laser treatment works best when the lesion type, pigment depth, wavelength, pulse duration, and fluence are matched to the underlying pathology rather than using a one-size-fits-all endpoint.
- Clinical endpoints are essential because they provide the practical bedside signal for balancing efficacy and safety when exact fluence thresholds are not available.
- For superficial epidermal pigment, a subtle immediate whitening or light-frost endpoint is usually sufficient, while aggressive whitening adds little benefit and increases the risk of post-inflammatory hyperpigmentation.
- Dermal pigment requires different, more conservative endpoints than epidermal lesions, and visible frosted whitening or pinpoint bleeding often indicates excessive injury.
- Patients with darker skin are at substantially higher risk of post-inflammatory hyperpigmentation, so lower-fluence and more cautious treatment strategies are favored.
- Picosecond and other photoacoustic approaches generally produce less thermal spread than nanosecond photothermal lasers, making them safer for many pigmentary indications in skin of color.
- Mixed and complex pigmentary disorders should not be treated with the same endpoint used for simple lentigines, because over-treatment can worsen melasma or cause hypopigmentation and textural damage.
- Warning endpoints such as persistent frosting, pucker sign, charring, or blue-gray discoloration should prompt stopping or reassessing treatment before complications occur.
- Histology and noninvasive imaging such as RCM, OCT, and line-field confocal OCT can confirm pigment depth and tissue response without repeated biopsy.
- The overall message is that precision dermatology for pigmentary disease depends on endpoint-guided, imaging-informed, individualized laser use rather than escalating power, passes, or session frequency.
- Dermatol Surg. 2008;34:1465-8.
- J Dermatol Treat. 2017;28:447-451.
- Dermatol Surg. 2020;46:1671-1675.
- Science. 1983;220:524-7.